Eko Health, a company specializing in AI-driven disease detection tools, announced the appointment of Justin Spencer as the new CFO. Spencer joins the executive team in Emeryville, California, bringing a wealth of financial leadership expertise. Previously, he held CFO positions at Vocera Communications (acquired by Stryker), Symmetricom, and Covad Communications.
“We’re pleased to have Justin as part of Eko’s executive leadership as CFO,” stated Connor Landgraf, co-founder and CEO of Eko Health. “Justin’s history of growing tech companies, navigating pivotal changes, and achieving outstanding financial performance makes him a crucial addition to our team. His knowledge is vital as we aim to enhance global access to early cardiac detection.”
Eko revealed that Spencer’s hiring coincides with a series of major achievements for the company. Recently, Eko secured a notable reimbursement victory following a $41 million Series D funding round. Additionally, in April 2024, the company received FDA authorization for its AI algorithm meant to aid in the diagnosis of heart failure.
With Spencer steering its financial strategy and operations, Eko is prepared for continued growth.
“I am delighted to join Eko Health at such a significant phase in its development,” expressed Spencer. “The company is revolutionizing the way clinicians identify and manage cardiopulmonary diseases with its groundbreaking AI tools, making a tangible difference in patients’ lives. My career has led me to seek roles that blend transformative technology with impactful results, which is exactly what Eko represents. I’m eager to help expand its platform to reach countless healthcare professionals and patients globally, ensuring the company realizes both its mission and its strategic financial objectives.”